Therapeutic Catalyst supports academic researchers in early drug discovery, funding target identification, validation and early antibody or small molecule development to advance treatments for adult cancers.
Childhood Cancer Therapeutic Catalyst supports academic researchers in collaborative early drug discovery to advance novel therapeutics for children and young people with cancer.
Discovery Programme Award supports established researchers pursuing ambitious basic and early-stage translational research to answer fundamental questions in cancer biology and underpin therapeutic development.
Cancer Research UK's CDD supports the development of novel cancer agents from preclinical stages to early clinical trials with expert resources, not monetary funding.
Catapult Award supports researchers conducting Phase 1 and Phase 2 pediatric cancer trials, moving promising laboratory findings into patient testing to advance better, less-toxic treatments for children.
Discovery Programme Foundation Award supports mid-career researchers developing independent cancer biology programmes to deepen understanding of cancer and build scientific leadership.